Year To Quarter End Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7736363

Concept 2017-04-01 to
2017-06-30
2016-04-01 to
2016-06-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
11,509,000,000 JPY
11,851,000,000 JPY
Cost of sales
8,194,000,000 JPY
8,365,000,000 JPY
Gross profit (loss)
3,314,000,000 JPY
3,486,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
3,168,000,000 JPY
3,210,000,000 JPY
Operating profit (loss)
145,000,000 JPY
275,000,000 JPY
Non-operating income
Interest income
5,000,000 JPY
5,000,000 JPY
Dividend income
38,000,000 JPY
37,000,000 JPY
Non-operating income
223,000,000 JPY
211,000,000 JPY
Non-operating expenses
Interest expenses
50,000,000 JPY
53,000,000 JPY
Non-operating expenses
91,000,000 JPY
92,000,000 JPY
Ordinary profit (loss)
278,000,000 JPY
394,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
JPY
5,000,000 JPY
Extraordinary losses
0 JPY
15,000,000 JPY
Profit (loss) before income taxes
277,000,000 JPY
379,000,000 JPY
Income taxes - current
8,000,000 JPY
175,000,000 JPY
Income taxes - deferred
77,000,000 JPY
-83,000,000 JPY
Income taxes
85,000,000 JPY
92,000,000 JPY
Profit (loss)
192,000,000 JPY
287,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.